MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT signaling in dendritic cells after stem cell transplantation.
MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT signaling in dendritic cells after stem cell transplantation.
复制标题
DOI:
10.1038/leu.2017.137
复制
发表时间:
2017-12
期刊:
影响因子:
11.4
通讯作者:
Zeiser R
中科院分区:
文献类型:
--
作者:
Stickel N;Hanke K;Marschner D;Prinz G;Köhler M;Melchinger W;Pfeifer D;Schmitt-Graeff A;Brummer T;Heine A;Brossart P;Wolf D;von Bubnoff N;Finke J;Duyster J;Ferrara J;Salzer U;Zeiser R
Acute Graft-versus-host disease (GVHD) is a major immunological complication after allogeneic hematopoietic cell transplantation and a better understanding of the molecular regulation of the disease could help to develop novel targeted therapies. Here we found that a G/C polymorphism within the human microRNA-146a (miR-146a) gene of transplant-recipients, which causes reduced miR-146a levels, was strongly associated with the risk of developing severe acute GVHD (n=289). In mice, deficiency of miR-146a in the hematopoietic system or transfer of recipient-type miR 146a-/- dendritic cells (DCs) enhanced GVHD, while miR-146a mimic-transfected-DCs ameliorated disease. Mechanistically, lack of miR-146a enhanced JAK2 STAT1-pathway activity, which led to higher expression of class II-transactivator (CIITA) and consecutively increased MHCII-levels on DCs. Inhibition of JAK1/2 or CIITA knockdown in DCs prevented miR-146a-/- DC-induced GVHD exacerbation. Consistent with our findings in mice, patients with the miR-146a polymorphism rs2910164 in hematopoietic cells displayed higher MHCII levels on monocytes, which could be targeted by JAK1/2-inhibition. Our findings indicate that the miR-146a polymorphism rs2910164 identifies patients at high risk for GVHD before allo HCT. Functionally we show that miR-146a acts as a central regulator of recipient-type DC activation during GVHD by dampening the pro-inflammatory JAK-STAT/CIITA/MHCII axis, which provides a scientific rationale for early JAK1/2-inhibition in selected patients.
登录
查看更多内容
DOI:
10.1038/nrmicro2321
发表时间:
2010-04
期刊:
Nature reviews. Microbiology
影响因子:
--
作者:
通讯作者:
--
影响因子:
11.4
作者:
Zeiser R;Burchert A;Lengerke C;Verbeek M;Maas-Bauer K;Metzelder SK;Spoerl S;Ditschkowski M;Ecsedi M;Sockel K;Ayuk F;Ajib S;de Fontbrune FS;Na IK;Penter L;Holtick U;Wolf D;Schuler E;Meyer E;Apostolova P;Bertz H;Marks R;Lübbert M;Wäsch R;Scheid C;Stölzel F;Ordemann R;Bug G;Kobbe G;Negrin R;Brune M;Spyridonidis A;Schmitt-Gräff A;van der Velden W;Huls G;Mielke S;Grigoleit GU;Kuball J;Flynn R;Ihorst G;Du J;Blazar BR;Arnold R;Kröger N;Passweg J;Halter J;Socié G;Beelen D;Peschel C;Neubauer A;Finke J;Duyster J;von Bubnoff N
通讯作者:
von Bubnoff N
影响因子:
4.4
作者:
Jurkin, Jennifer;Schichl, Yvonne M.;Strobl, Herbert
通讯作者:
Strobl, Herbert
DOI:
10.1073/pnas.0802682105
发表时间:
2008-05-20
影响因子:
11.1
作者:
Jazdzewski, Krystian;Murray, Elizabeth L.;de la Chapelle, Albert
通讯作者:
de la Chapelle, Albert
影响因子:
2.8
作者:
Yang, Yan;Zhang, Kui;Zhou, Rong
通讯作者:
Zhou, Rong